RxDoctor Payments Data

Richard Pecunia, MD

Plastic Surgery · Hattiesburg, MSNPI 1205944659

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,347 of the $7,082 with a category attached, or 75.5%. AbbVie accounts for 66.2% of it on its own, with 20 other manufacturers making up the rest.

$7,082in general payments, 2019–2025

Across 251 payments — averaging $28.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • Motiva USA, LLC$578
  • Revance Therapeutics, Inc.$482
  • Galderma Laboratories, L.p.$255
  • Merz North America, Inc.$217
  • Integra Lifesciences Corporation$148
  • plus $716 from 15 others
$7,184in research payments, 2019–2025

Across 4 payments — averaging $1796.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$7K

What the payments were for

  • Travel & lodging$1,73525%
  • Food & beverage$5,34775%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,082 in reported general payments places this provider in the 75th percentile of 25 plastic surgery providers in Mississippi.

See all plastic surgery providers in Mississippi

Medicare billing

Part B allowed, 2024
$92,078
Medicare patients
174
Services billed
1,126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen136$699
Famotidine155$138
Ondansetron Hcl19$83

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Hattiesburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →